The NHANES program suspended field operation in March 2020 due to the coronavirus disease 2019 (COVID-19) pandemic. As a result, data collection for the NHANES 2019-2020 cycle was not completed and the collected data are not nationally representative. Therefore, data collected from 2019 to March 2020 were combined with data from the NHANES 2017-2018 cycle to form a nationally representative sample of NHANES 2017-March 2020 pre-pandemic data. These data are available to the public. Please refer to the Analytic Notes section for more details on the use of the data.
Organophosphate (OP) pesticides are used in both residential and agricultural settings in the United States. OP pesticides include malathion, diazinon, chlorpyrifos, Guthion® (azinphosmethyl), parathion, and many others. All OP pesticides have a common mode of toxicity because they are competitive inhibitors of acetylcholinesterase, the enzyme responsible for deacetylation of the neurotransmitter acetylcholine (Koelle G.B., 1994; Gompertz D., 1996). Unfortunately, the toxic effects of OP pesticides are not unique to insects; high doses can similarly affect wildlife and people.
OP pesticides were among the first of the U.S. Environmental Protection Agency (EPA)-registered pesticides whose food tolerances were reassessed (EPA, 2017), due to their common mode of toxicity and potential adverse effects in vulnerable populations, such as children.
Most of the organophosphate pesticides registered for use in the United States by the EPA are O, O-dimethyl, or O-diethyl substituted, which metabolize to dialkylphosphate (DAP) metabolites. The six common DAP metabolites (Dimethylphosphate, Diethylphosphate, Dimethylthiophosphate, Dimethyldithiophosphate, Diethylthiophosphate, and Diethyldithiophosphate) do not retain any of the structure unique to the pesticides from which they were derived, so it is impossible to identify individual pesticides from these metabolites. However, because these metabolites are common to the majority of OP pesticides, they can provide invaluable information about cumulative exposure to the OP class.
All examined participants aged 3 to 5 years and a one-third subsample of examined participants aged 6 years and older were eligible in the NHANES 2017-March 2020 pre-pandemic sample.
This method uses solid phase extraction (SPE) coupled with isotope dilution-ultrahigh performance liquid chromatography (UHPLC)-tandem mass spectrometry (Jayatilaka N.K., et. al., 2017). The method relies on an enzymatic hydrolysis of urinary conjugates, automated off-line SPE to pre-concentrate the target compounds while minimizing urine matrix potential interferences to increase the overall sensitivity and specificity. The deconjugated target analytes in the urine extract are separated on an UHPLC system with reversed phase chromatography and quantified by isotope dilution tandem mass spectrometry.
Refer to the Laboratory Method Files section for a detailed description of the laboratory methods used.
There were no changes to the lab method, lab equipment, and lab site for this component in the NHANES 2017-2018 or 2019-2020 cycles.
Organophosphate Insecticides- Dialkyl Phosphate Metabolites (OPD) (March 2022)
Organophosphate Insecticides - Dialkyl Phosphate Metabolites - Urine (November 2023)
Urine specimens are processed, stored, and shipped to the Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA for analysis.
Detailed instructions on specimen collection and processing are discussed in the 2017-2018 and 2019-2020 NHANES Laboratory Procedures Manual (LPM). Vials were stored under appropriate frozen (–30°C) conditions until they were shipped to the Division of Laboratory Sciences for testing.
The NHANES quality control and quality assurance protocols (QA/QC) meet the 1988 Clinical Laboratory Improvement Amendments mandates. Detailed QA/QC instructions are discussed in the NHANES LPM.
Mobile Examination Centers (MECs)
Laboratory team performance is monitored using several techniques. NCHS and contract consultants use a structured competency assessment evaluation during visits to evaluate both the quality of the laboratory work and the quality-control procedures. Each laboratory staff member is observed for equipment operation, specimen collection and preparation; testing procedures and constructive feedback are given to each staff member. Formal retraining sessions are conducted annually to ensure that required skill levels were maintained.
Analytical Laboratories
NHANES uses several methods to monitor the quality of the analyses performed by the contract laboratories. In the MEC, these methods include performing blind split samples collected during “dry run” sessions. In addition, contract laboratories randomly perform repeat testing on 2% of all specimens.
NCHS developed and distributed a QC protocol for all CDC and contract laboratories, which outlined the use of Westgard rules (Westgard, et. al., 1981) when running NHANES specimens. Progress reports containing any problems encountered during shipping or receipt of specimens, summary statistics for each control pool, QC graphs, instrument calibration, reagents, and any special considerations are submitted to NCHS quarterly. The reports are reviewed for trends or shifts in the data. The laboratories are required to explain any identified areas of concern.
All QC procedures recommended by the manufacturers were followed. Reported results for all assays meet the Division of Laboratory Sciences’ QA/QC performance criteria for accuracy and precision, similar to the Westgard rules (Caudill et. al., 2008).
The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.
The COVID-19 pandemic required suspension of NHANES 2019-2020 field operations in March 2020 after data were collected in 18 of the 30 survey locations in the 2019-2020 sample. Data collection was cancelled for the remaining 12 locations. Because the collected data from 18 locations were not nationally representative, these data were combined with data from the previous cycle (2017-2018) to create a 2017-March 2020 pre-pandemic data file. A special weighting process was applied to the 2017-March 2020 pre-pandemic data file. The resulting sample weights in the present file should be used to calculate estimates from the combined cycles. These sample weights are not appropriate for independent analyses of the 2019-2020 data and will not yield nationally representative results for either the 2017-2018 data alone or the 2019-March 2020 data alone. Please refer to the NHANES website for additional information for the NHANES 2017-March 2020 pre-pandemic data, and for the previous 2017-2018 public use data file with specific weights for that 2-year cycle.
Refer to the 2017-2018 and 2019-2020 Laboratory Data Overview for general information on NHANES laboratory data.
There are over 800 laboratory tests performed on NHANES participants. However, not all participants provided biospecimens or enough volume for all the tests to be performed. The specimen availability can also vary by age or other population characteristics. Analysts should evaluate the extent of missing data in the dataset related to the outcome of interest as well as any predictor variables used in the analyses to determine whether additional re-weighting for item non-response is necessary.
Please refer to the NHANES Analytic Guidelines and the on-line NHANES Tutorial for further details on the use of sample weights and other analytic issues.
Subsample Weights
Organophosphate Pesticides - Dialkyl Phosphate Metabolites were measured in a one-third subsample of participants 6 years and older. Special sample weights are required to analyze these data properly. Specific sample weights for this subsample are included in this data file and should be used when analyzing these data.
For participants aged 3-5, their sample weights in this dataset (i.e., WTSBPRP) are equivalent to their MEC exam sample weights. These participants have completed at least one physical exam component in the MEC; therefore, they all have an exam sample weight larger than “0,” regardless of their lab test results. For participants 6 years and older in the dataset, special sample weights were created for the subsample and encoded in variable WTSBPRP. These special weights accounted for the additional probability of selection into the subsample, as well as the additional nonresponse to these lab tests. Therefore, if participants 6 years and older were selected as part of the one-third subsample, but did not provide a urine specimen, they would have the sample weight value assigned as “0” in their records.
Demographic and Other Related Variables
The analysis of NHANES laboratory data must be conducted using the appropriate survey design and demographic variables. The NHANES 2017- March 2020 Demographics File contains demographic data, health indicators, and other related information collected during household interviews as well as the sample design variables. The recommended procedure for variance estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file.
This laboratory data file can be linked to the other NHANES data files using the unique survey participant identifier (i.e., SEQN).
Detection Limits
The detection limit was constant for the analyte in the data set. Two variables are provided for this analyte. The variable name ending in “LC” (ex., URDOP1LC) indicates whether the result was below the limit of detection: the value “0” means that the result was at or above the limit of detection, “1” indicates that the result was below the limit of detection. For the analyte with analytic results below the lower limit of detection (URDOP1LC=1), an imputed fill value was placed in the analyte results field. This value is the lower limit of detection divided by square root of 2 (LLOD/sqrt [2]). The variable prefixed URX (ex., URXOP1) provides the analytic result for that analyte.
The lower limit of detection (LLOD, in ng/mL) for Organophosphate Pesticides - Dialkyl Phosphate Metabolites:
Variable Name | Analyte Description | LLOD |
---|---|---|
URXOP1 | Dimethylphosphate (ng/mL) | 0.1 |
URXOP2 | Diethylphosphate (ng/mL) | 0.1 |
URXOP3 | Dimethylthiophosphate (ng/mL) | 0.1 |
URXOP4 | Diethylthiophosphate (ng/mL) | 0.1 |
URXOP5 | Dimethyldithiophosphate (ng/mL) | 0.1 |
URXOP6 | Diethyldithiophosphate (ng/mL) | 0.1 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
2462.026927 to 981259.61533 | Range of Values | 4646 | 4646 | |
0 | Participants 6+ years with no lab specimen | 283 | 4929 | |
. | Missing | 0 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0.0707 to 622 | Range of Values | 4618 | 4618 | |
. | Missing | 311 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0 | At or above the detection limit | 4383 | 4383 | |
1 | Below lower detection limit | 235 | 4618 | |
. | Missing | 311 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0.0707 to 252 | Range of Values | 4607 | 4607 | |
. | Missing | 322 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0 | At or above the detection limit | 4585 | 4585 | |
1 | Below lower detection limit | 22 | 4607 | |
. | Missing | 322 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0.0707 to 454 | Range of Values | 4604 | 4604 | |
. | Missing | 325 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0 | At or above the detection limit | 4075 | 4075 | |
1 | Below lower detection limit | 529 | 4604 | |
. | Missing | 325 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0.0707 to 34 | Range of Values | 4611 | 4611 | |
. | Missing | 318 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0 | At or above the detection limit | 2674 | 2674 | |
1 | Below lower detection limit | 1937 | 4611 | |
. | Missing | 318 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0.0707 to 175 | Range of Values | 4621 | 4621 | |
. | Missing | 308 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0 | At or above the detection limit | 2192 | 2192 | |
1 | Below lower detection limit | 2429 | 4621 | |
. | Missing | 308 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0.0707 to 1.27 | Range of Values | 4620 | 4620 | |
. | Missing | 309 | 4929 |
Code or Value | Value Description | Count | Cumulative | Skip to Item |
---|---|---|---|---|
0 | At or above the detection limit | 156 | 156 | |
1 | Below lower detection limit | 4464 | 4620 | |
. | Missing | 309 | 4929 |